Industries > Pharma > Drug Delivery Technologies: Commercial Prospects 2013-2023

Drug Delivery Technologies: Commercial Prospects 2013-2023

PUBLISHED: 03 May 2013
PAGES: 189
PRODUCT CODE:

Clear
WOOCS 2.2.1

Drug delivery technology – discover technological and commercial prospects

What does the future hold for drug delivery technologies? Visiongain’s report shows you potential revenues and other trends, with data, forecasts and discussions. Many commercial opportunities for improved drug delivery exist. You discover sales predictions to 2023 at world market, submarket, application and national level.

Forecasts and other analyses to help you stay ahead in knowledge

In our work you find revenue forecasting to 2023, historical data, growth rates and market shares. You see qualitative analysis (SWOT analysis), business news, outlooks and developmental trends. You gain 59 tables, 34 charts and 7 research interviews.

Is finding commercial details a challenge? With our report you can get ahead in knowledge, benefiting your research, analyses and decisions. Discover areas that will prosper, reducing the risk of your being left behind.

You discover industry dynamics and growth potentials – the following sections show what you find in our new report.

Discover prospects for the world market and submarkets

Along with revenue prediction for the overall world market, you see forecasts to 2023 for these submarkets:
• Oral delivery
• Inhaled delivery
• Transdermal delivery
• Ocular delivery
• Nasal delivery
• Implants for drug delivery

The study discusses 3M, Catalent, Alkermes, Generex Biotechnology, pSivida, Antares Pharma and many other technology providers, letting you assess outlooks for the industry and market.

How will biological drugs using the technologies perform from 2013? You find overall revenues from nine pharmaceutical areas predicted to 2023:
• Monoclonal antibodies
• Insulins
• Erythropoietins
• Interferons
• G-CSF agents
• Recombinant coagulation factors
• Other therapeutic proteins
• Biosimilars and related agents
• Vaccines.

Where is drug delivery heading? Technologies and applications giving improved clinical efficacy, patient convenience and treatment compliance will achieve success.

Drug delivery R&D is promising. Suppliers and users of the technology will benefit. Our calculations show you the potential for expanded revenues to 2023.

Which areas of pharma will benefit most? Drug delivery technologies offer many opportunities for pharma line extensions and product lifecycle management, benefiting a wide range of drugs. Biologicals and vaccines will profit especially. You see how.

In our analysis, the drug delivery technology industry will achieve high revenue growth from 2013 to 2023. In particular, greater use of injectable drugs and vaccines worldwide will stimulate demand for innovative delivery systems.

We find wide scope for novel and improved drug delivery from 2013 onwards, seeing many sales opportunities for products and services there. Our report explains.

Visiongain’s study provides data, analysis and opinion aiming to benefit your research, calculations and presentations. You find answers in our work.

What prospects for leading regions and countries?

Developments worldwide will influence the market from 2013, especially the expansion of healthcare in emerging countries. There exist many opportunities for companies developing drug delivery technologies. Market growth will be driven by opportunities in biological drug and vaccine sectors. See prospects for the industry.

You get individual forecasts to 2023 for nine national markets, finding overall revenues:
• US
• Japan
• Germany, France, UK, Italy and Spain
• India and China.

Discover progress and outlooks. You assess the industry’s future – hear about developments and find their significance. Our work explains, exploring many issues.

Eight ways Drug Delivery Technologies: Commercial Prospects 2013-2023 helps

To sum up, our investigation gives you the following knowledge:
• Revenues to 2023 for the overall world market and 6 submarkets – you discover that industry’s prospects
• Forecasting to 2023 for the US, Japan, Germany, France, UK, Spain, Italy, India and China – you see leading national sales potentials
• Assessments of biological drug markets – discover prospects for drug delivery technologies from 2013
• Assessments of leading companies – you find activities, products, capabilities and outlooks
• Opinions on the sector – you read our industry interviews
• Understanding of competition and opportunities – you see what affects that industry, learning what shapes its future
• Analysis of what stimulates and restrains the industry and market – you assess challenges and strengths
• Prospects for established firms and those seeking to enter the sector – you explore needs, practices and outlooks for success.

Benefit from our analyses, gaining information found nowhere else

That work gives independent analysis from our primary and secondary research. You receive business intelligence found only in our study, seeing where prospects are lucrative and growth is likely.

With our report you are less likely to fall behind in knowledge or miss opportunity. See how our work could benefit your research, analyses and decisions, saving you time and getting you recognition for commercial insight.

Discover technological and commercial prospects from 2013 by ordering now

Our study is for everybody needing industry and market analyses for drug delivery technologies. You find data, trends and answers there. Avoid missing out – please order our report now.

Visiongain is a trading partner with the US Federal Government
CCR Ref number: KD4R6
To view free sample pages of this report please click here

Download sample pages

Complete the form below to download your free sample pages for Drug Delivery Technologies: Commercial Prospects 2013-2023


Download sample pages

Complete the form below to download your free sample pages for Drug Delivery Technologies: Commercial Prospects 2013-2023


Latest Pharma news

Visiongain Publishes Checkpoint Inhibitors for Treating Cancer Market Report 2021-2031

We predict strong revenue growth through to 2031. Our work identifies which organizations hold the greatest potential. Discover their capabilities, progress, and commercial prospects, helping you stay ahead.

29 July 2021

READ

Visiongain Publishes Direct-to-Patient Market Report 2021-2031

Over the last few years, Direct-to-Patient has gained widespread attention. DTP companies offer their customers, who are patients, in this case, all kinds of services.

21 July 2021

READ

Visiongain Publishes Drug Delivery Technologies Market Report 2021-2031

Rising geriatric population, increasing prevalence of chronic and infectious diseases, escalating investment in drug R&D by biopharmaceutical companies, rising demand for advanced drug delivery technologies for chronic treatment are some of the major factors that drive the growth of the global drug delivery technologies market.

20 July 2021

READ

Visiongain Publishes Pharma Contract Sales Market Report 2021-2031

Pharma services companies are widening their service offerings (either organically or inorganically through M&A) to become full-service providers, simplifying their customers’ operations and gaining the maximum share of their outsourcing budgets, driven by the willingness of pharma to reduce the number of outsourcers they use.

14 July 2021

READ

Categories